An Update From Our Team Regarding COVID-19 – California Governor Gavin Newsom issued a mandatory statewide order to ‘stay at home’ effective Thursday, March 19th. Governor Newsome has declared a full shutdown of non-essential … Ver Mas

An Update From Our Team Regarding COVID-19 – California Governor Gavin Newsom issued a mandatory statewide order to ‘stay at home’ effective Thursday, March 19th. Governor Newsome has declared a full shutdown of non-essential … Ver Mas
Categorías News and Events
U.S. FDA approves Eisai’s DayVigo (Lemborexant) for the treatment of insomnia in adult patients! The FDA approved the new drug application for its in-house discovered and developed orexin receptor antagonist DayVigo (lemborexant). DayVigo was … Ver Mas
Categorías News and Events
Idorsia announces positive results in the first Phase 3 study of daridorexant with improved overall sleep and daytime performance of patients with insomnia! We are very pleased to share with you the top line … Ver Mas
Categorías News and Events
Oficina Corporativa
770 Washington St, Ste 200
San Diego, CA 92103
Teléfono: 858-278-3647
Fax: 619-629-0512
Localización San Diego
770 Washington Street, Suite 300
San Diego, CA 92103
Teléfono: 858-278-3647
Fax: 858-278-3660
Reclutamiento de pacientes: 1-855-DoStudies1-855-367-8834)
Localización Riverside
11748 Magnolia Ave, Suite D
Riverside, CA 92503
Teléfono: 951-374-1190
Fax: 951-374-7245
Reclutamiento de pacientes: 1-855-DoStudies1-855-367-8834)
Artemis Institute is a Headlands Research Site
El Insituto de Artemis es una sucursal de Headlands Research
© 2025 Artemis Institute for Clinical Research • Comentarios Sobre Accesibilidad • Developed by TinyFrog